Tags

Type your tag names separated by a space and hit enter

Advances in technology for management of type 1 diabetes.
Lancet 2019; 394(10205):1265-1273Lct

Abstract

Technological advances have had a major effect on the management of type 1 diabetes. In addition to blood glucose meters, devices used by people with type 1 diabetes include insulin pumps, continuous glucose monitors, and, most recently, systems that combine both a pump and a monitor for algorithm-driven automation of insulin delivery. In the next 5 years, as many advances are expected in technology for the management of diabetes as there have been in the past 5 years, with improvements in continuous glucose monitoring and more available choices of systems that automate insulin delivery. Expansion of the use of technology will be needed beyond endocrinology practices to primary-care settings and broader populations of patients. Tools to support decision making will also need to be developed to help patients and health-care providers to use the output of these devices to optimise diabetes management.

Authors+Show Affiliations

Jaeb Center for Health Research, Tampa, FL, USA. Electronic address: rbeck@jaeb.org.International Diabetes Center, Park Nicollet and Health Partners, Minneapolis, MN, USA.Joslin Diabetes Center, Harvard Medical School, Boston, MA, USA.King's College London, Faculty of Life Sciences and Medicine, Guy's Hospital, London, UK.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

31533908

Citation

Beck, Roy W., et al. "Advances in Technology for Management of Type 1 Diabetes." Lancet (London, England), vol. 394, no. 10205, 2019, pp. 1265-1273.
Beck RW, Bergenstal RM, Laffel LM, et al. Advances in technology for management of type 1 diabetes. Lancet. 2019;394(10205):1265-1273.
Beck, R. W., Bergenstal, R. M., Laffel, L. M., & Pickup, J. C. (2019). Advances in technology for management of type 1 diabetes. Lancet (London, England), 394(10205), pp. 1265-1273. doi:10.1016/S0140-6736(19)31142-0.
Beck RW, et al. Advances in Technology for Management of Type 1 Diabetes. Lancet. 2019 10 5;394(10205):1265-1273. PubMed PMID: 31533908.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Advances in technology for management of type 1 diabetes. AU - Beck,Roy W, AU - Bergenstal,Richard M, AU - Laffel,Lori M, AU - Pickup,John C, Y1 - 2019/09/15/ PY - 2019/01/31/received PY - 2019/04/26/revised PY - 2019/05/01/accepted PY - 2019/9/20/pubmed PY - 2019/10/24/medline PY - 2019/9/20/entrez SP - 1265 EP - 1273 JF - Lancet (London, England) JO - Lancet VL - 394 IS - 10205 N2 - Technological advances have had a major effect on the management of type 1 diabetes. In addition to blood glucose meters, devices used by people with type 1 diabetes include insulin pumps, continuous glucose monitors, and, most recently, systems that combine both a pump and a monitor for algorithm-driven automation of insulin delivery. In the next 5 years, as many advances are expected in technology for the management of diabetes as there have been in the past 5 years, with improvements in continuous glucose monitoring and more available choices of systems that automate insulin delivery. Expansion of the use of technology will be needed beyond endocrinology practices to primary-care settings and broader populations of patients. Tools to support decision making will also need to be developed to help patients and health-care providers to use the output of these devices to optimise diabetes management. SN - 1474-547X UR - https://www.unboundmedicine.com/medline/citation/31533908/Advances_in_technology_for_management_of_type_1_diabetes L2 - https://linkinghub.elsevier.com/retrieve/pii/S0140-6736(19)31142-0 DB - PRIME DP - Unbound Medicine ER -